Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067.
Chagomerana MB, Moser CB, Kang M, Umbleja T, Hughes MD, Campbell TB, Krown SE, Borok MZ, Samaneka W, Ngongondo M, Nyirenda M, Langat DC, Hoagland B, Burger H, Busakhala N, Njiru E, Mwelase N, Mngqibisa R, Hosseinipour MC. Chagomerana MB, et al. Among authors: ngongondo m. J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):216-225. doi: 10.1097/QAI.0000000000003484. J Acquir Immune Defic Syndr. 2024. PMID: 39431505 Clinical Trial.
Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials.
Ngongondo M, Ritz J, Hughes MD, Matoga M, Hosseinipour MC; AIDS Clinical Trials Group A5208, A5221, A5175 and A5274 Study Teams. Ngongondo M, et al. PLOS Glob Public Health. 2024 Jan 4;4(1):e0002648. doi: 10.1371/journal.pgph.0002648. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38175824 Free PMC article.
Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
Matoga MM, Bisson GP, Gupta A, Miyahara S, Sun X, Fry C, Manabe YC, Kumwenda J, Cecilia K, Nyirenda M, Ngongondo M, Mbewe A, Lagat D, Wallis C, Mugerwa H, Hosseinipour MC. Matoga MM, et al. Among authors: ngongondo m. Clin Infect Dis. 2021 Aug 16;73(4):e870-e877. doi: 10.1093/cid/ciab179. Clin Infect Dis. 2021. PMID: 34398958 Free PMC article.
Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy.
Nyirenda M, Ngongondo M, Kang M, Umbleja T, Krown SE, Godfrey C, Samaneka W, Mngqibisa R, Hoagland B, Mwelase N, Caruso S, Martinez-Maza O, Dittmer DP, Borok M, Hosseinipour MC, Campbell TB; A5264/AMC-067 team. Nyirenda M, et al. Among authors: ngongondo m. J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):422-429. doi: 10.1097/QAI.0000000000002361. J Acquir Immune Defic Syndr. 2020. PMID: 32265361 Free PMC article. Clinical Trial.
Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ, DiPrete BL, Jumbe AN, Ngongondo M, Limarzi L, Wallie SD, Chagomerana MB, Hosseinipour MC; S4 Study Team. Harrington BJ, et al. Among authors: ngongondo m. Trop Med Int Health. 2019 Oct;24(10):1221-1228. doi: 10.1111/tmi.13296. Epub 2019 Aug 19. Trop Med Int Health. 2019. PMID: 31381233 Free article.
Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
Ngongondo M, Miyahara S, Hughes MD, Sun X, Bisson GP, Gupta A, Kumwenda J, Lavenberg JA, Torres TS, Nyirenda M, Kidonge KK, Hosseinipour MC; AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Ngongondo M, et al. J Acquir Immune Defic Syndr. 2018 May 1;78(1):54-61. doi: 10.1097/QAI.0000000000001641. J Acquir Immune Defic Syndr. 2018. PMID: 29406428 Free PMC article. Clinical Trial.
Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings.
Torres TS, Harrison LJ, La Rosa AM, Lavenberg JA, Zheng L, Safren SA, Ngongondo M, Poongulali S, Matoga M, Samaneka W, Collier AC, Hughes MD. Torres TS, et al. Among authors: ngongondo m. AIDS Care. 2018 Aug;30(8):954-962. doi: 10.1080/09540121.2018.1427207. Epub 2018 Jan 18. AIDS Care. 2018. PMID: 29343078 Free PMC article. Clinical Trial.
Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women.
Torres TS, Harrison LJ, La Rosa AM, Cardoso SW, Zheng L, Ngongondo M, Some F, Lalloo UG, Mwelase T, Collier AC, Hughes MD; AIDS Clinical Trials Group (ACTG) A5273 Study Group. Torres TS, et al. Among authors: ngongondo m. AIDS. 2018 Mar 13;32(5):583-593. doi: 10.1097/QAD.0000000000001738. AIDS. 2018. PMID: 29334547 Free PMC article. Clinical Trial.
13 results